Company Analysis

Cardio Diagnostics Holdings Inc. (CDIO)

Nasdaq: CDIO · In Vitro & In Vivo Diagnostic Substances · Chicago, IL · filing with the SEC since 2021
Grade4.8
◀ Past 3.4● Present 4.6▶ Future 5.8
1 est.

Who runs Cardio Diagnostics Holdings Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
0
of 4 people with a filing in the last fifteen months
Directors reporting now
4
16 people on the record since 2021
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Betts Wendy JdirectorFeb 2025Oct 2, 2026none
Burton Paul FrederickdirectorJan 2024Oct 2, 2026none
Fung Peter KdirectorMar 2025Oct 2, 2026none
Intrater JamesdirectorNov 2022Oct 2, 2026none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CDIO · research, not advice